Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jerry D Cavallerano, O.D., Ph.D.

Co-Author

This page shows the publications co-authored by Jerry Cavallerano and Jennifer Sun.
Connection Strength

1.592
  1. Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity. Transl Vis Sci Technol. 2020 06; 9(7):10.
    View in: PubMed
    Score: 0.219
  2. Future Promise of and Potential Pitfalls for Automated Detection of Diabetic Retinopathy. JAMA Ophthalmol. 2016 Feb; 134(2):210-1.
    View in: PubMed
    Score: 0.162
  3. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011 Apr; 34(4):968-74.
    View in: PubMed
    Score: 0.116
  4. Visual acuity testing using autorefraction or pinhole occluder compared with a manual protocol refraction in individuals with diabetes. Ophthalmology. 2011 Mar; 118(3):537-42.
    View in: PubMed
    Score: 0.112
  5. Effects of dilation on electronic-ETDRS visual acuity in diabetic patients. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1580-4.
    View in: PubMed
    Score: 0.098
  6. Association of Maximizing Visible Retinal Area by Manual Eyelid Lifting With Grading of Diabetic Retinopathy Severity and Detection of Predominantly Peripheral Lesions When Using Ultra-Widefield Imaging. JAMA Ophthalmol. 2022 Feb 24.
    View in: PubMed
    Score: 0.062
  7. Ultrawide Field Imaging in Diabetic Retinopathy: Exploring the Role of Quantitative Metrics. J Clin Med. 2021 Jul 27; 10(15).
    View in: PubMed
    Score: 0.059
  8. Factors Affecting Predominantly Peripheral Lesion Identification and Grading. Transl Vis Sci Technol. 2021 06 01; 10(7):6.
    View in: PubMed
    Score: 0.059
  9. Retinal Vascular Caliber Association with Nonperfusion and Diabetic Retinopathy Severity Depends on Vascular Caliber Measurement Location. Ophthalmol Retina. 2021 06; 5(6):571-579.
    View in: PubMed
    Score: 0.056
  10. Disparity of microaneurysm count between ultrawide field colour imaging and ultrawide field fluorescein angiography in eyes with diabetic retinopathy. Br J Ophthalmol. 2020 12; 104(12):1762-1767.
    View in: PubMed
    Score: 0.054
  11. Long-Term Effect on HbA1c in Poorly Controlled Diabetic Patients Following Nonmydriatic Retinal Image Review at the Time of Endocrinology Visit. Telemed J E Health. 2020 10; 26(10):1265-1270.
    View in: PubMed
    Score: 0.053
  12. Hemorrhage and/or Microaneurysm Severity and Count in Ultrawide Field Images and Early Treatment Diabetic Retinopathy Study Photography. Ophthalmology. 2017 07; 124(7):970-976.
    View in: PubMed
    Score: 0.044
  13. Evidence for Telemedicine for Diabetic Retinal Disease. Semin Ophthalmol. 2017; 32(1):22-28.
    View in: PubMed
    Score: 0.043
  14. Identification of Diabetic Retinopathy and Ungradable Image Rate with Ultrawide Field Imaging in a National Teleophthalmology Program. Ophthalmology. 2016 06; 123(6):1360-7.
    View in: PubMed
    Score: 0.041
  15. Comparison of Nondiabetic Retinal Findings Identified With Nonmydriatic Fundus Photography vs Ultrawide Field Imaging in an Ocular Telehealth Program. JAMA Ophthalmol. 2016 Mar; 134(3):330-4.
    View in: PubMed
    Score: 0.041
  16. Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography. Ophthalmology. 2015 Dec; 122(12):2465-72.
    View in: PubMed
    Score: 0.039
  17. Real-Time Ultrawide Field Image Evaluation of Retinopathy in a Diabetes Telemedicine Program. Diabetes Care. 2015 Sep; 38(9):1643-9.
    View in: PubMed
    Score: 0.039
  18. Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years. Ophthalmology. 2015 May; 122(5):949-56.
    View in: PubMed
    Score: 0.038
  19. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014 Oct; 34(10):1960-8.
    View in: PubMed
    Score: 0.037
  20. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014; 37(1):50-5.
    View in: PubMed
    Score: 0.034
  21. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology. 2013 Dec; 120(12):2587-2595.
    View in: PubMed
    Score: 0.034
  22. Comparison of low-light nonmydriatic digital imaging with 35-mm ETDRS seven-standard field stereo color fundus photographs and clinical examination. Telemed J E Health. 2012 Sep; 18(7):492-9.
    View in: PubMed
    Score: 0.032
  23. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012 Sep; 154(3):549-559.e2.
    View in: PubMed
    Score: 0.031
  24. Automated Retinal Imaging System (ARIS) compared with ETDRS protocol color stereoscopic retinal photography to assess level of diabetic retinopathy. Diabetes Technol Ther. 2012 Jun; 14(6):515-22.
    View in: PubMed
    Score: 0.031
  25. Nonmydriatic retinal image review at time of endocrinology visit results in short-term HbA1c reduction in poorly controlled patients with diabetic retinopathy. Telemed J E Health. 2011 Jul-Aug; 17(6):415-9.
    View in: PubMed
    Score: 0.029
  26. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 2010 Sep; 6(9):494-508.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.